Connecticut Attorney General William Tong announced four separate settlements with hearing aid companies: Lively Hearing Corporation, Widex USA, Inc., Hark Wellness, Inc., and Wonder Ear, Inc., who marketed their products as “FDA-approved” despite no such approval.
Hearing aids currently do not receive approval from the United States Food and Drug Administration (FDA) in the same manner as new drugs and some medical devices; however, hearing aid manufacturers register their products with the FDA.
Although Congress enacted legislation in 2017 permitting the FDA to create a category of over-the-counter (OTC) hearing aids, the FDA has not yet issued a final rule and no hearing aid suppliers should be marketing their products as OTC or “FDA-approved.”
Recent Posts
Medicaid Work Requirements Rule Could Affect Access to Hearing Healthcare
The Centers for Medicare and Medicaid Services (CMS) recently issued an Interim Final Rule implementing Medicaid work requirements for certain adult beneficiaries beginning in 2027….
Sleep in U.S. Adults
Previously, we reported on sleep routines and tiredness in children. You may now be wondering how well adults sleep. If so, a recent report by…
Audiology CPT® Codes Enter Routine AMA RUC Review Process
Over the next several months, a significant number of CPT® codes used to report audiology function tests will undergo review through the AMA/Specialty Society Relative…


